Randomized Controlled Trial Comparing the Efficacy & Safety of FMT in

Clinical Trial Summary

Data for stool microbiome will be collected for all the chronic hepatitis B subjects (pre cirrhotic,compensated,decompensated and reactivation). All the in and out patient with Hepatitis B reactivation will be recruited and randomized into two arms.

Group 1 Tenofovir Group 2 Tenofovir with FMT (Fecal Microbiota Transplant).

Tenofovir would be given 300 mg once daily FMT through NJ (Naso-Jejunal) tube for 7 days.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06069284` - Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure
Recruiting	`NCT03754400` - Efficacy of Albumin Therapy With Standard Medical Treatment (SMT) as Compared to Standard Medical Treatment (SMT) in Improving Patient Survival and Immune Modulation in Patients With Acute on Chronic Liver Failure (ASIA Trial).	N/A
Not yet recruiting	`NCT06066814` - To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
Completed	`NCT02573727` - To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure	N/A
Completed	`NCT02583698` - Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices	N/A
Not yet recruiting	`NCT06116305` - Lactate Kinetics as a Predictor of Survival in ACLF With Septic Shock
Completed	`NCT01074645` - Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure	Phase 4
Recruiting	`NCT05124041` - Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy	N/A
Not yet recruiting	`NCT06340269` - Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF	N/A
Recruiting	`NCT01866072` - Evaluation of Role of Transient Elastography (Fibroscan) in Differentiating Patients of Acute Severe Viral Hepatitis and Acute on Chronic Liver Failure	N/A
Terminated	`NCT02788240` - To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase	N/A
Not yet recruiting	`NCT05772585` - Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
Withdrawn	`NCT05131230` - CytoSorb® in Patients With Acute on Chronic Liver Failure
Completed	`NCT02467348` - Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.	N/A
Not yet recruiting	`NCT06276907` - An Open-label Randomized Controlled Trial Comparing the Role of Therapeutic Plasma-exchange in Ameliorating Secondary Organ Dysfunctions in Patients With ACLF and Develop Biomarkers of Treatment Response	N/A
Recruiting	`NCT05146336` - CytOSorb TreatMent Of Critically Ill PatientS Registry
Completed	`NCT02307409` - Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis	N/A
Completed	`NCT03065699` - Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients	N/A
Recruiting	`NCT02757170` - Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography	Phase 4
Recruiting	`NCT04054037` - A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study)

NCT number	NCT02689245
Study type	Interventional
Source	Institute of Liver and Biliary Sciences, India
Contact
Status	Completed
Phase	N/A
Start date	February 26, 2016
Completion date	March 13, 2018

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms